Clinical Trial Update: BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update shows BXQ-350 is being studied in newly diagnosed metastatic colorectal carcinoma in Phase 1/Phase 2. The study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Carcinoma

Drugs mentioned

• BXQ-350

Snippet

Sponsor: Bexion Pharmaceuticals, Inc. | Conditions: Metastatic Colorectal Carcinoma, Neuropathy | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING